https://orcid.org/0000-0003-4476-6510
References
- De Stefano V. Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome. Haematologica. 2018;103(9):1419. doi:10.3324/haematol.2018.19781430171017
- Kato M, Shukuya T, Mori K, et al. Cerebral infarction in advanced non-small cell lung cancer: a case control study. BMC Cancer. 2016;16:203. doi:10.1186/s12885-016-2233-126964872
- Takano H, Nakajima K, Nagayoshi Y, et al. Clinical associations of Trousseau’s syndrome associated with cerebral infarction and ovarian cancer. J Gynecol Oncol. 2018;29(5). doi:10.3802/jgo.2018.29.e67
- Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340–1347. doi:10.1161/CIRCRESAHA.115.30684127126645
- Grilz E, Konigsbrugge O, Posch F, et al. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. Haematologica. 2018;103(9):1549–1556. doi:10.3324/haematol.2018.19241929794142
- Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K. Trousseau’s syndrome: cancer-associated thrombosis. Jpn J Clin Oncol. 2016;46(3):204–208. doi:10.1093/jjco/hyv16526546690
- Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544. doi:10.1016/S0140-6736(16)31012-127733281
- Umemura T, Yamamoto J, Akiba D, Nishizawa S. Bilateral cerebral embolism as a characteristic feature of patients with Trousseau syndrome. J Clin Neurosci. 2017;42:155–159. doi:10.1016/j.jocn.2017.04.01428431956
- Siegel RL, Miller KD, Jemal AA-O. Cancer statistics 2018 . CA Cancer J Clin. 2018;68(1):7–30. ( 1542–4863 (Electronic)).29313949
- Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70(8):926–938. doi:10.1016/j.jacc.2017.06.04728818202
- Navi BB, Singer S, Merkler AE, et al. Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke. Stroke. 2014;45(8):2292–2297. doi:10.1161/STROKEAHA.114.00578424994717
- Grazioli S, Paciaroni M, Agnelli G, et al. Cancer-associated ischemic stroke: a retrospective multicentre cohort study. Thromb Res. 2018;165:33–37. ( 1879–2472 (Electronic)). doi:10.1016/j.thromres.2018.03.01129558659
- Qureshi AI, Malik AA, Saeed O, Adil MM, Rodriguez GJ, Suri MFK. Incident cancer in a cohort of 3,247 cancer diagnosis free ischemic stroke patients. Cerebrovascular Dis. 2015;39(5–6):262–268. doi:10.1159/000375154
- Ishikawa M, Nakayama K, Ishibashi T, et al. Case series of cerebral infarction with Trousseau’s syndrome associated with malignant gynecological tumors. Mol Clin Oncol. 2016;5:138–142. ( 2049–9450 (Print)). doi:10.3892/mco.2016.88827330786
- Kikuchi K, Ueda A, Nagao R, et al. Changes in serial d-dimer levels predict the prognoses of trousseau’s syndrome patients. Front Neurol. 2018;9(undefined):528. doi:10.3389/fneur.2018.0052830018592
- Del Conde I, Bharwani LD, Dietzen DJ, Pendurthi U, Thiagarajan P, Lopez JA. Microvesicle-associated tissue factor and Trousseau’s syndrome. J Thromb Haemost. 2007;5(1):70–74. doi:10.1111/j.1538-7836.2006.02301.x17239164
- Yeşilot N, Ekizoğlu E, Çoban O. Clinical features of cancer associated ischemic stroke. Noro psikiyatri ars. 2018;55(2):113–117. doi:10.29399/npa.22999
- Kneihsl M, Enzinger C, Wünsch G, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263(1):150–156. doi:10.1007/s00415-015-7954-626530513
- Naito H, Nezu T, Hosomi N, et al. Antithrombotic therapy strategy for cancer-associated ischemic stroke: a case series of 26 patients. J Stroke Cerebrovasc Dis. 2018;27(9):. doi:10.1016/j.jstrokecerebrovasdis.2018.04.021